20 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/20/3046184/33240/en/Hikma-announces-Health-Canada-approval-of-KLOXXADO-naloxone-HCl-Nasal-Spray-8-mg.html
10 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/10/3039648/0/en/Polyrizon-Initiates-Preclinical-Studies-for-Intranasal-Naloxone-Targeting-Opioid-Overdose-Based-on-Its-Innovative-T-T-Platform.html
06 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/06/3038102/0/en/SCIENTURE-to-commercially-launch-REZENOPY-a-life-saving-opioid-overdose-emergency-treatment-through-a-collaboration-with-KINDEVA-DRUG-DELIVERY-L-P.html
03 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/padagis-naloxone-now-the-lowest-priced-opioid-overdose-treatment-available-on-amazon-302366429.html
21 Dec 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/how-save-fentanyl-victim-key-facts-about-naloxone-2024-12-21/
23 Nov 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/astrazeneca-cans-phase-2-opioid-use-disorder-drug-over-interaction-antifungal